Introduction
============

Fournier\'s gangrene is characterized by necrotizing fasciitis of the perineal, perianal or genital regions ([@B1], [@B2]). Diabetes mellitus is well known to be a particularly important risk factor for Fournier\'s gangrene ([@B2], [@B3]). Fournier\'s gangrene is typically caused by polymicrobial infection ([@B2]). It has been increasingly reported that monomicrobial infection of community-associated methicillin-resistant *Staphylococcus aureus* (CA-MRSA) can cause necrotizing fasciitis ([@B4]).

In the USA, the most predominant CA-MRSA strain, USA300, belongs to multilocus sequence type (ST) 8 and typically harbors virulence genes, such as the Panton-Valentine leukocidin genes *lukF-PV* and *lukS-PV* (*luk~PV~SF*), and staphylococcal cassette chromosome *mec* (*SCCmec*) type IV carrying penicillin and cephem resistance gene *mecA* ([@B4]).

In Japan, the strain ST8 has not been well characterized ([@B5]) despite several studies showing evidence of USA300 infection ([@B6]-[@B10]). We herein report a case of monomicrobial Fournier\'s gangrene caused by a strain of methicillin-susceptible *S. aureus* ST8 (designated ksw1) that lacked the Panton-Valentine leukocidin gene while harboring the toxic shock syndrome toxin-1 gene.

Case Report
===========

A 66-year-old man presented with a 1-month history of left buttock pain. His medical records indicated type 2 diabetes mellitus that had not been treated for 30 years. The patient had never been abroad. A clinical examination revealed tachycardia (100 beats per minute) with a normal blood pressure (105/55 mmHg) and slight pyrexia (38.1°C). His body mass index was 18.64 kg/m^2^ (height, 167 cm; body weight, 52.0 kg). A physical examination revealed an open wound with purulent discharge on his left buttock ([Figure a](#g001){ref-type="fig"}). A laboratory examination indicated leucocytosis (white blood cell count, 23,820 /μL), elevated level of C-reactive protein (C-reactive protein, 25.08 mg/dL), mildly elevated level of muscle-derived enzymes (aspartate aminotransferase, 90 U/L; lactate dehydrogenase, 433 U/L; creatine kinase, 322 U/L), normal level of serum creatinine (creatinine, 0.59 mg/dL) and hyperglycemia (blood glucose, 238 mg/dL; hemoglobin A1c, 8.6%). Furthermore, computed tomography (CT) demonstrated subcutaneous emphysema extending from the left scrotum and inguinal region to the left thigh ([Figure b](#g001){ref-type="fig"}). The CT findings indicated the possibility of Fournier\'s gangrene. In accordance with this observation, intravenous tazobactam/piperacillin (4.5 g, thrice daily) was initiated, and exploratory surgery was conducted. Concurrently, insulin therapy was started to manage his hyperglycemia. Intraoperative findings revealed subcutaneous abscess in the left buttock with necrotizing muscle fascia, symptomatically confirming Fournier\'s gangrene. Accordingly, extensive debridement was conducted.

![(a) Open wound on the left buttock of the patient. (b) CT scan of subcutaneous emphysema. CT: computed tomography](1349-7235-59-1769-g001){#g001}

Gram staining of the intraoperative purulence demonstrated clusters of Gram-positive cocci, indicating the involvement of *S. aureus*. Therefore, intravenous vancomycin was added. Monomicrobial *S. aureus* was isolated from the blood and intraoperative purulence samples. This isolate was tested for antimicrobial susceptibility by the microliquid dilution method using an autoSCAN-4 (Beckman Coulter, Brea, USA) and the CLSI M100-S26 interpretive criteria and was found to be resistant to penicillin and ampicillin while retaining susceptibility to the other 14 antimicrobials examined (sulbactam/ampicillin, cefazolin, cefotiam, cefmetazole, flomoxef, gentamicin, arbekacin, erythromycin, minocycline, vancomycin, sulfamethoxazole/trimethoprim, fosfomycin, imipenem/cilastatin and levofloxacin). Based on the results of an antimicrobial susceptibility test, antimicrobials were replaced with intravenous cefazolin (1 g thrice daily) and clindamycin (600 mg twice daily). Repeated CT revealed a residual lesion in the left scrotum. Accordingly, additional debridement was performed on day 19 of admission. After the second debridement, antimicrobials were replaced with levofloxacin (500 mg once daily) administered orally and discontinued 3 days after the surgery.

The genome of the *S. aureus* strain isolated from the intraoperative purulence (ksw1) was sequenced with an MiSeq sequencer (illumina, San Diego, USA), and genome assembly was performed with a CLC Genomics Workbench 11. Multilocus sequence typing ([@B11]) and *spa* (protein A gene) typing ([@B12]) were conducted, and the genotype was determined to be ST8/*spa*1 (t622). We further performed gene annotation with the Pathosystems Resource Integration Center (PATRIC, <http://www.patricbrc.org>) ([@B13]) and searched for SCC*mec* using the SCC*mec*Finder (<http://cge.cbs.dtu.dk/services/SCCmecFinder>) ([@B14]). We compared the virulence factors between ksw1, USA300 strain FPR3757 (GenBank accession number: CP000255) ([@B15]) and ST8 CA-MRSA/J strain NN50 (Genbank accession number: BAEA01000000) ([@B16]), which is the major genotype of ST8 in Japan ([Table](#t001){ref-type="table"}). The ksw1 lacked *luk~PV~SF* and harbored the toxic shock syndrome toxin-1 gene, like ST8 CA-MRSA/J, but lacked SCC*mec*. For further confirmation, we conducted polymerase chain reaction (PCR) for *luk~PV~SF* genes using two primer sets: Fw (5\'-CATCAACAGGAGGTAATGG) and Rv (5\'-CAGAATAAATGTTTCCAGCAGC). We did not detect a 751-bp PCR product that could have been generated if the strain harbors *luk~PV~SF* genes. This confirms that the strain lacks *luk~PV~SF* genes. The genome sequence of the isolated strain has been deposited in the public sequence repository DNA Data Bank of Japan, DDBJ (<http://www.ddbj.nig.ac.jp>), under the accession number: PRJDB8899 (DDBJ BioProject), SAMD00193980 (ksw1) (DDBJ BioSample).

###### 

The Comparison of Multilocus Sequence Types and Virulence Factors between Ksw1, ST8 CA-MRSA/J and USA300.

  ---------------------------------------------------------------------------------------------------------------------------------
  Type, virulence gene,\   ksw1                               ST8 CA-MRSA/J -MM50                USA300 -FPR3757
  drug resistance                                                                                
  ------------------------ ---------------------------------- ---------------------------------- ----------------------------------
  Type                                                                                           

  ST                       8                                  8                                  8

  *spa*                    1 (t622)                           1 (t1767)                          1 (t008)

  SCC*mec*                 \-                                 IV                                 IVa

  virulence genes                                                                                

  leukocidins                                                                                    

  *luk~PV~SF*              \-                                 \-                                 \+

  *lukED*                  \+                                 \+                                 \+

  phenol-soluble modulin                                                                         

  *hld*                                                                                          

  hemolysins               \+                                 \+                                 \+

  *hla*                    \+                                 \+                                 \+

  *hlb*                    \+                                 \+                                 \+

  *hlg*                    \+                                 \+                                 \+

  *tsst-1*                 \+                                 \+                                 \-

  enterotoxins             *sec*, *sel*, *sep*                *sec*, *sel*, *sep*                *sek*, *seq*

  adhesins                 *ebpS*, *sdrC*, *sdrD*, *sdrE*,\   *ebpS*, *sdrC*, *sdrD*, *sdrE*,\   *ebpS*, *sdrC*, *sdrD*, *sdrE*,\
                           icaA, icaB, icaC, icaD,\           icaA, icaB, icaC, icaD,\           icaA, icaB, icaC, icaD,\
                           icaR, clfB                         icaR, clfB                         icaR, clfB

  others                   *sak*, *scn*                       *sak*, *scn*                       *sak*, *scn*, *chp*

  drug resistance          PCG, ABPC                          PCG, DMPPC, EM, GM ^1^             β lactams, EM, CLDM,\
                                                                                                 TC, CPFX, MUP
  ---------------------------------------------------------------------------------------------------------------------------------

^1^ Computational Prediction. PCG: benzylpenicillin, ABPC: ampicillin, DMPPC: methicillin, EM: erythromycin, GM: gentamicin, CLDM: clindamycin, TC: tetracycline, CPFX: ciprofloxacin, MUP: mupirocin

Discussion
==========

We encountered a case of monomicrobial Fournier\'s gangrene caused by Panton-Valentine leukocidin-negative methicillin-susceptible *S. aureus* ST8 in a patient with type 2 diabetes mellitus. The clinical course of necrotizing fasciitis caused by CA-MRSA is reported to be subacute, with symptoms presenting an average of six days before admission ([@B4]). In the present case, left buttock pain had been noticed one month before admission, and a residual lesion in the left scrotum developed over two weeks after the first debridement. Therefore, the clinical course of the present case is considerably persistent.

The isolated strain ksw1 was found to share its ST8 with USA300, the most predominant CA-MRSA strain in the USA and known to cause skin and soft tissue infection. Epidemiological studies have demonstrated an association between CA-MRSA and the presence of *luk~PV~SF* genes and SCC*mec* type IV ([@B17]-[@B19]). Panton-Valentine leukocidin is a cytotoxin that induces apoptosis of human neutrophils, and intradermal injection of purified Panton-Valentine leukocidin to rabbits reportedly induces tissue necrosis ([@B20], [@B21]). Therefore, Panton-Valentine leukocidin has been considered to be responsible for the enhanced virulence of CA-MRSA strains. However, several experimental studies in animal models of skin and soft tissue infection have shown a minimal effect of Panton-Valentine leukocidin ([@B22]-[@B24]). Furthermore, five cases of invasive infection reported in South Korea were found to be caused by Panton-Valentine leukocidin-negative CA-MRSA ([@B25]). This evidence negates the significant role of Panton-Valentine leukocidin as a virulence factor in skin and soft tissue infections caused by CA-MRSA. Interestingly, our observations also indicate that Panton-Valentine leukocidin is dispensable in causing necrotizing fasciitis.

The virulence factor composition of ksw1 differed considerably from that of the USA300 strain. Besides lacking Panton-Valentine leukocidin, ksw1 was found to harbor the toxic shock syndrome toxin-1 gene. Regarding the virulence factor composition, ksw1 showed high similarities to ST8 CA-MRSA/J, a major genotype of ST8 CA-MRSA in Japan ([@B16]). Furthermore, the *spa* type of ksw1, 1 (t622) includes variant strains of ST8 CA-MRSA/J ([@B16]). More detailed studies involving comparative genomics, especially of the gene structure including SCC*mec*, are desired.
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